A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines
Sébastien Taurin(University of Otago), Rhonda J. Rosengren(University of Otago)
Cited by 13
Related Papers
Phosphorylation of β-Catenin by Cyclic AMP-dependent Protein Kinase
|Journal of Biological Chemistry|2006|458
RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER-negative breast cancer models
|International Journal of Oncology|2012|26
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
|International Journal of Nanomedicine|2016|20